Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages

Richard L Kravitz, Naihua Duan, Joel Braslow

Research output: Contribution to journalArticle

303 Citations (Scopus)

Abstract

Evidence-based medicine is the application of scientific evidence to clinical practice. This article discusses the difficulties of applying global evidence ("average effects" measured as population means) to local problems (individual patients or groups who might depart from the population average). It argues that the benefit or harm of most treatments in clinical trials can be misleading and fail to reveal the potentially complex mixture of substantial benefits for some, little benefit for many, and harm for a few. Heterogeneity of treatment effects reflects patient diversity in risk of disease, responsiveness to treatment, vulnerability to adverse effects, and utility for different outcomes. Recognizing these factors, researchers can design studies that better characterize who will benefit from medical treatments, and clinicians and policymakers can make better use of the results.

Original languageEnglish (US)
Pages (from-to)661-687
Number of pages27
JournalMilbank Quarterly
Volume82
Issue number4
DOIs
StatePublished - 2004

Fingerprint

Evidence-Based Medicine
medicine
evidence
physician's care
vulnerability
Therapeutics
Complex Mixtures
Population
Disease
Research Personnel
Clinical Trials
Group

Keywords

  • Evidence-based medicine
  • Genomics
  • Population characteristics
  • Research design
  • Statistics
  • United States Food And Drug Administration

ASJC Scopus subject areas

  • Nursing(all)
  • Health(social science)
  • Health Professions(all)
  • Health Policy

Cite this

Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. / Kravitz, Richard L; Duan, Naihua; Braslow, Joel.

In: Milbank Quarterly, Vol. 82, No. 4, 2004, p. 661-687.

Research output: Contribution to journalArticle

@article{393ec961a183440d8eebc74c38c430db,
title = "Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages",
abstract = "Evidence-based medicine is the application of scientific evidence to clinical practice. This article discusses the difficulties of applying global evidence ({"}average effects{"} measured as population means) to local problems (individual patients or groups who might depart from the population average). It argues that the benefit or harm of most treatments in clinical trials can be misleading and fail to reveal the potentially complex mixture of substantial benefits for some, little benefit for many, and harm for a few. Heterogeneity of treatment effects reflects patient diversity in risk of disease, responsiveness to treatment, vulnerability to adverse effects, and utility for different outcomes. Recognizing these factors, researchers can design studies that better characterize who will benefit from medical treatments, and clinicians and policymakers can make better use of the results.",
keywords = "Evidence-based medicine, Genomics, Population characteristics, Research design, Statistics, United States Food And Drug Administration",
author = "Kravitz, {Richard L} and Naihua Duan and Joel Braslow",
year = "2004",
doi = "10.1111/j.0887-378X.2004.00327.x",
language = "English (US)",
volume = "82",
pages = "661--687",
journal = "Milbank Quarterly",
issn = "0887-378X",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages

AU - Kravitz, Richard L

AU - Duan, Naihua

AU - Braslow, Joel

PY - 2004

Y1 - 2004

N2 - Evidence-based medicine is the application of scientific evidence to clinical practice. This article discusses the difficulties of applying global evidence ("average effects" measured as population means) to local problems (individual patients or groups who might depart from the population average). It argues that the benefit or harm of most treatments in clinical trials can be misleading and fail to reveal the potentially complex mixture of substantial benefits for some, little benefit for many, and harm for a few. Heterogeneity of treatment effects reflects patient diversity in risk of disease, responsiveness to treatment, vulnerability to adverse effects, and utility for different outcomes. Recognizing these factors, researchers can design studies that better characterize who will benefit from medical treatments, and clinicians and policymakers can make better use of the results.

AB - Evidence-based medicine is the application of scientific evidence to clinical practice. This article discusses the difficulties of applying global evidence ("average effects" measured as population means) to local problems (individual patients or groups who might depart from the population average). It argues that the benefit or harm of most treatments in clinical trials can be misleading and fail to reveal the potentially complex mixture of substantial benefits for some, little benefit for many, and harm for a few. Heterogeneity of treatment effects reflects patient diversity in risk of disease, responsiveness to treatment, vulnerability to adverse effects, and utility for different outcomes. Recognizing these factors, researchers can design studies that better characterize who will benefit from medical treatments, and clinicians and policymakers can make better use of the results.

KW - Evidence-based medicine

KW - Genomics

KW - Population characteristics

KW - Research design

KW - Statistics

KW - United States Food And Drug Administration

UR - http://www.scopus.com/inward/record.url?scp=12444289440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444289440&partnerID=8YFLogxK

U2 - 10.1111/j.0887-378X.2004.00327.x

DO - 10.1111/j.0887-378X.2004.00327.x

M3 - Article

C2 - 15595946

AN - SCOPUS:12444289440

VL - 82

SP - 661

EP - 687

JO - Milbank Quarterly

JF - Milbank Quarterly

SN - 0887-378X

IS - 4

ER -